Tag: 180-day exclusivity

8

Jan
180-Day Exclusivity in Generic Drugs: How Patent Challenges Delay Market Entry

180-Day Exclusivity in Generic Drugs: How Patent Challenges Delay Market Entry

The 180-day exclusivity rule under the Hatch-Waxman Act gives the first generic drug challenger a temporary monopoly to incentivize patent challenges-but it often delays market entry for years, keeping prices high. Here's how it works and why it matters.

READ MORE